Literature DB >> 803520

Serum antibody response in acute brucellosis.

I D Farrell, L Robertson, P M Hinchliffe.   

Abstract

The serum antibody titres in 62 cases of acute brucellosis are presented. The antibody persisiting after infection and the appearance of non-agglutinating anti-human globulin titres were investigated. The criteria for the serological diagnosis of acute and chronic brucellosis are discussed.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 803520      PMCID： PMC2131545          DOI： 10.1017/s0022172400046672

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


  3 in total

1.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

2.  The antiglobulin (Coombs) test in brucellosis.

Authors:  M M WILSON; E V O MERRIFIED
Journal:  Lancet       Date:  1951-11-17       Impact factor: 79.321

3.  Techniques and interpretations in the serological diagnosis of brucellosis in man.

Authors:  W R Kerr; W J McCaughey; J D Coghlan; D J Payne; R A Quaife; L Robertson; I D Farrell
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472
  3 in total
  3 in total

1.  The use of the microagglutination technique to determine the antibody status of healthy New Zealanders to Brucella abortus.

Authors:  K A Bettelheim; W J Maskill; R V Metcalfe; J L Pearce
Journal:  J Hyg (Lond)       Date:  1984-06

2.  Thermostable cross-protective subunit vaccine against Brucella species.

Authors:  John W Cherwonogrodzky; Nicole D Barabé; Michelle L Grigat; William E Lee; Robert T Poirier; Scott J Jager; Bradley J Berger
Journal:  Clin Vaccine Immunol       Date:  2014-10-15

3.  Estimating Loss of Brucella Abortus Antibodies from Age-Specific Serological Data In Elk.

Authors:  J A Benavides; D Caillaud; B M Scurlock; E J Maichak; W H Edwards; P C Cross
Journal:  Ecohealth       Date:  2017-05-15       Impact factor: 3.184
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.